Literature DB >> 16703289

Quantifying radioxerostomia: salivary flow rate, examiner's score, and quality of life questionnaire.

Bilal Al-Nawas1, Katy Al-Nawas, Martin Kunkel, Knut A Grötz.   

Abstract

BACKGROUND AND
PURPOSE: Salivary flow rates alone are not sufficient to quantify all aspects of radioxerostomia. This is a problem in studies aiming to reduce radioxerostomia. The aim of this study was to evaluate the association between objectively measured salivary flow rate and subjective xerostomia ratings by the physician (RTOG scale) or the patients (quality of life [QoL] questionnaire). PATIENTS AND METHODS: In a case-control study patients who underwent recall for oral cancer were screened. Inclusion criteria for this diagnostic, noninterventional study were: history of oral carcinoma, surgical and radiation therapy, time interval from start of radiation therapy > 90 days, salivary glands within the radiation field. The control group consisted of patients, who had not received radiotherapy. RTOG salivary gland score, quality of life (EORTC QLQ-C30 and H&N35), and sialometry were recorded.
RESULTS: Patients with RTOG score 0 had mean salivary flow rates of 0.3 ml/min, those with RTOG 1 0.12 ml/min, RTOG 2 0.02 ml/min, and RTOG 3 < 0.01 ml/min. RTOG score 4 (total fibrosis) did not occur. Based on salivary flow rates, all patients were grouped into xerostomia < 0.2 ml/min (30 patients) and nonxerostomia (twelve patients). QoL results revealed significant differences between patients with xerostomia and nonxerostomia for physical function, dyspnea, swallowing, social eating, dry mouth, nutritional support, and a tendency to higher values for appetite loss.
CONCLUSION: The correlation between "subjective" QoL parameters and salivary flow was confirmed. The different subjective aspects of radioxerostomia seem to be better differentiated by the EORTC QoL questionnaire.

Entities:  

Mesh:

Year:  2006        PMID: 16703289     DOI: 10.1007/s00066-006-1508-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

Review 1.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

2.  Impact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients.

Authors:  Mary P Walker; Brian Wichman; An-Lin Cheng; James Coster; Karen B Williams
Journal:  Pract Radiat Oncol       Date:  2011

3.  Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.

Authors:  Julia Karbach; Christian Walter; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2011-09-09       Impact factor: 3.573

4.  Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy.

Authors:  Luiz Felipe Palma; Fernanda Aurora Stabile Gonnelli; Marcelo Marcucci; Rodrigo Souza Dias; Adelmo José Giordani; Roberto Araújo Segreto; Helena Regina Comodo Segreto
Journal:  Lasers Med Sci       Date:  2017-03-03       Impact factor: 3.161

5.  Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin.

Authors:  Anna Delana; Loris Menegotti; Andrea Bolner; Luigi Tomio; Aldo Valentini; Frank Lohr; Valentina Vanoni
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

6.  Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients.

Authors:  Alessio Aghemo; Maria Grazia Rumi; Sara Monico; Matteo Banderali; Antonio Russo; Francesco Ottaviani; Mauro Vigano; Roberta D'Ambrosio; Massimo Colombo
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

7.  Risk factors for reduced salivary flow rate in a Japanese population: the Hisayama Study.

Authors:  Kenji Takeuchi; Michiko Furuta; Toru Takeshita; Yukie Shibata; Yoshihiro Shimazaki; Sumio Akifusa; Toshiharu Ninomiya; Yutaka Kiyohara; Yoshihisa Yamashita
Journal:  Biomed Res Int       Date:  2015-02-03       Impact factor: 3.411

Review 8.  Levels of scientific evidence of the quality of life in patients treated for oral cancer.

Authors:  Rocío Barrios; Javier Montero; Miguel-Angel González-Moles; Pilar Baca; Manuel Bravo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01

9.  Apparent diffusion coefficient histogram analysis can evaluate radiation-induced parotid damage and predict late xerostomia degree in nasopharyngeal carcinoma.

Authors:  Nan Zhou; Tingting Guo; Huanhuan Zheng; Xia Pan; Chen Chu; Xin Dou; Ming Li; Song Liu; Lijing Zhu; Baorui Liu; Weibo Chen; Jian He; Jing Yan; Zhengyang Zhou; Xiaofeng Yang
Journal:  Oncotarget       Date:  2017-07-26

10.  A novel method to evaluate salivary flow rates of head and neck cancer patients after radiotherapy: a pilot study.

Authors:  Luiz Felipe Palma; Fernanda Aurora Stabile Gonnelli; Marcelo Marcucci; Adelmo José Giordani; Rodrigo Souza Dias; Roberto Araújo Segreto; Helena Regina Comodo Segreto
Journal:  Braz J Otorhinolaryngol       Date:  2017-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.